Catalyst Pharmaceuticals ...
22.63
0.44 (1.98%)
At close: Jan 15, 2025, 12:29 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04
Net Income 71.41M 83.08M 39.48M 74.98M 31.88M -34.00M -18.41M -18.07M -20.23M -15.51M -12.15M -4.08M -6.39M -4.01M -7.24M -10.56M -4.14M -2.73M -1.81M -539.82K
Depreciation & Amortization 32.88M 1.24M 192.00K 885.32K 297.73K 37.98K 45.69K 43.41K 34.47K 26.57K 22.48K 10.89K 42.84K 25.74K 30.23K 32.76K 15.76K 4.93K 1.37K 366.00
Stock-Based Compensation 14.25M 7.91M 6.07M 6.26M 3.82M 3.55M 2.41M 1.84M 1.59M 777.97K 175.85K 340.04K 416.74K 450.09K 601.44K 717.57K 556.34K 1.22M n/a n/a
Other Working Capital -330.00K 15.28M 10.36M -6.11M 9.56M 4.37M 1.02M -23.45K 682.90K -194.55K 705.10K -1.39M 468.53K -83.21K -989.85K 1.44M -629.34K -55.06K n/a n/a
Other Non-Cash Items 80.20M 5.16M 287.00K -12.19K -290.81K 3.68M 186.90K -886.14K 1.59M 993.87K 2.07M 340.04K 319.91K 450.09K 601.44K 717.57K 556.34K 1.22M 1.17M 294.83K
Deferred Income Tax -17.82M 4.94M 9.32M -32.97M n/a n/a n/a n/a -1.65M n/a -175.85K -1.47M n/a -450.09K -601.44K -717.57K -556.34K -1.22M n/a n/a
Change in Working Capital -37.32M 13.73M 5.02M -4.11M -1.10M 4.71M 2.03M -884.40K 662.82K 768.87K 190.22K -285.13K 626.53K -226.91K -1.07M 1.55M -857.54K 325.26K 175.90K 14.10K
Operating Cash Flow 143.60M 116.05M 60.37M 45.03M 34.61M -25.70M -13.74M -17.96M -18.02M -12.94M -9.88M -5.14M -4.99M -3.76M -7.68M -8.26M -4.42M -1.18M -455.36K -230.52K
Capital Expenditures -198.52M -29.00K -1.02M -11.40K -19.37K -92.02K n/a -96.06K -23.46K -57.32K -9.43K -52.38K -3.62K -2.87K -2.30K -1.34K -65.87K -21.05K -3.94K -1.83K
Acquisitions n/a 10.00M n/a 5.00M -37.24M n/a n/a 23.46K 23.46K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -13.46M -10.00M -10.00M -10.00M -34.73M -36.80M -3.96K -68.60K -1.85K -8.68M -7.49M -14.01M n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a 19.24M n/a 5.00M 71.97M 21.37M n/a 3.72M 18.81K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies -81.51M -10.00M -10.00M -5.00M 37.24M -14.99M -3.96K -23.46K -23.46K -8.68M -7.49M -14.01M n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow -293.50M 9.21M -11.02M -5.01M 37.22M -15.53M -3.96K 3.55M -6.50K -8.74M -7.50M -14.06M -3.62K -2.87K -2.30K -1.34K -65.87K -21.05K -3.94K -1.83K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.00M n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased -982.00K -6.91M -12.09M -56.00K n/a -4.45K n/a -11.27K n/a n/a n/a n/a n/a n/a n/a -3.41K n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -10.86M 8.60M 3.95M -56.20K 1.12M 293.12K 3.58M 68.99K 2.29M 1.84M 4.11M 16.25K n/a n/a n/a n/a n/a n/a n/a n/a
Financial Cash Flow -10.86M 1.69M -8.14M 701.93K 1.12M 293.12K 57.35M 68.99K 37.16M 28.56M 18.18M 14.58M 5.54M 1.46M 3.70M 4.08M n/a 20.86M 1.05M n/a
Net Cash Flow -160.76M 126.95M 41.21M 40.73M 72.95M -40.94M 43.60M -14.34M 19.14M 6.88M 806.02K -4.62M 553.91K -2.30M -3.99M -4.18M -4.49M 19.66M 587.22K -232.35K
Free Cash Flow -54.92M 116.02M 59.35M 45.02M 34.59M -25.80M -13.74M -18.06M -18.04M -13.00M -9.89M -5.19M -4.99M -3.76M -7.69M -8.26M -4.49M -1.20M -459.30K -232.35K

Create Price Alert on CPRX

Your price alert will notify you when the stock price is above 22.63.

Add to Watchlist